La recherche

Biostatistics and Epidemiology Office - Publications

Biostatistics and Epidemiology Office publications, 2024 (PDF document)

Biostatistics and Epidemiology Department - Overview

Biostatistics and Epidemiology Office

The Biostatistics and Epidemiology Office is part of the Clinical Research Division and has been labelled an Center for Data Handling by the National Cancer Institute (INCa) since 2007.

The Biostatistics and Epidemiology Office comprises about 40 members (statisticians, MDs in public health, pharmacists-statisticians, public health intern, data-managers, health economists, etc.) and has the following main missions:

Projects and Sponsorship Office

back to job offer list

back to clinical trials

Projects and Sponsorship Office

The Projects and Sponsorship Office fits into the Gustave Roussy’s goal to optimize its clinical research performance and to develop its ability to manage large national and international academic trials with high added value and to strengthen Gustave Roussy position as an expert and center of excellence to conduct pharma companies innovative trials.

Etudes et Recherche en Economie de la Santé - Membres de l'équipe

back to job offer list

back to clinical trials

Membres de l'équipe

Julia BONASTRE, Responsable Equipe ERES, Economiste, PhD Sciences Economiques
Isabelle BORGET, Pharmacienne /PhD Santé Publique (économie), PU-PH
Arnaud PAGES, Pharmacien / PhD Economie de la santé et Epidémiologie
Stéphanie FOULON, Médecin de Santé Publique, PhD Santé Publique (épidémiologie)
Arnaud BAYLE, Oncologue, PhD Santé Publique (économie)
Aldéric FRASLIN, Statisticien/Economiste, PhD Santé Publique (économie)
Farah ERDOGAN, Doctorante Santé Publique (économie)

Etudes et Recherche en Economie de la Santé - Publications

back to job offer list

back to clinical trials

Publications Etudes et Recherche en Economie de la Santé 2024-25

PFMG2025 contributors. PFMG2025-integrating genomic medicine into the national healthcare system in France. Lancet Reg Health Eur 2025
Fraslin AM, Stockholm T, Filleron T, Bertaut A, Blanc-Lapierre A, Marghadi J, Aupérin A, Bonastre J.
A microsimulation model based on healthcare pathways to estimate the impact of COVID-19 pandemic-induced delays on breast cancer mortality. Journal of Clinical Epidemiology 2025

Etudes et Recherche en Economie de la Santé - Thématique

back to job offer list

back to clinical trials

Au sein du Bureau Biostatistique et d’Epidémiologie de Gustave Roussy et de l’équipe de recherche Oncostat « Méthodologie et épidémiologie clinique en oncologie moléculaire », nos missions sont de :

Clinical Research

back to job offer list

back to clinical trials

A research with strong societal impact integrated with care

Research at Gustave Roussy meets society's needs related to cancer. It is integrated into care because it is in the context of care that the data on which the research is based are collected from patients, and it is for the care of patients that the results of the research are used.